Logo image of DNOW

DNOW INC (DNOW) Stock Fundamental Analysis

NYSE:DNOW - New York Stock Exchange, Inc. - US67011P1003 - Common Stock - Currency: USD

17.43  -0.07 (-0.4%)

After market: 17.43 0 (0%)

Fundamental Rating

5

DNOW gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 49 industry peers in the Trading Companies & Distributors industry. DNOW is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DNOW has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year DNOW was profitable.
In the past year DNOW had a positive cash flow from operations.
In multiple years DNOW reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: DNOW reported negative operating cash flow in multiple years.
DNOW Yearly Net Income VS EBIT VS OCF VS FCFDNOW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M -400M

1.2 Ratios

DNOW's Return On Assets of 12.73% is amongst the best of the industry. DNOW outperforms 95.83% of its industry peers.
DNOW's Return On Equity of 18.13% is fine compared to the rest of the industry. DNOW outperforms 64.58% of its industry peers.
DNOW has a Return On Invested Capital (8.78%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for DNOW is in line with the industry average of 9.86%.
The last Return On Invested Capital (8.78%) for DNOW is above the 3 year average (8.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.73%
ROE 18.13%
ROIC 8.78%
ROA(3y)8.68%
ROA(5y)-4.48%
ROE(3y)12.94%
ROE(5y)-6.15%
ROIC(3y)8.11%
ROIC(5y)N/A
DNOW Yearly ROA, ROE, ROICDNOW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

1.3 Margins

DNOW has a Profit Margin of 8.57%. This is in the better half of the industry: DNOW outperforms 77.08% of its industry peers.
DNOW's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 5.52%, DNOW is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of DNOW has grown nicely.
Looking at the Gross Margin, with a value of 22.78%, DNOW is doing worse than 72.92% of the companies in the same industry.
In the last couple of years the Gross Margin of DNOW has grown nicely.
Industry RankSector Rank
OM 5.52%
PM (TTM) 8.57%
GM 22.78%
OM growth 3YN/A
OM growth 5Y20.91%
PM growth 3YN/A
PM growth 5Y44.48%
GM growth 3Y8.52%
GM growth 5Y2.73%
DNOW Yearly Profit, Operating, Gross MarginsDNOW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DNOW is destroying value.
There is no outstanding debt for DNOW. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DNOW Yearly Shares OutstandingDNOW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
DNOW Yearly Total Debt VS Total AssetsDNOW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

DNOW has an Altman-Z score of 3.91. This indicates that DNOW is financially healthy and has little risk of bankruptcy at the moment.
DNOW has a better Altman-Z score (3.91) than 79.17% of its industry peers.
DNOW has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.91
ROIC/WACC0.81
WACC10.82%
DNOW Yearly LT Debt VS Equity VS FCFDNOW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B

2.3 Liquidity

DNOW has a Current Ratio of 2.54. This indicates that DNOW is financially healthy and has no problem in meeting its short term obligations.
DNOW has a better Current ratio (2.54) than 68.75% of its industry peers.
DNOW has a Quick Ratio of 1.66. This is a normal value and indicates that DNOW is financially healthy and should not expect problems in meeting its short term obligations.
DNOW has a better Quick ratio (1.66) than 72.92% of its industry peers.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 1.66
DNOW Yearly Current Assets VS Current LiabilitesDNOW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

The earnings per share for DNOW have decreased by -5.15% in the last year.
DNOW shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.83% yearly.
EPS 1Y (TTM)-5.15%
EPS 3Y97.18%
EPS 5Y30.83%
EPS Q2Q%13.64%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.88%

3.2 Future

Based on estimates for the next years, DNOW will show a small growth in Earnings Per Share. The EPS will grow by 3.62% on average per year.
DNOW is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.12% yearly.
EPS Next Y-6.59%
EPS Next 2Y2.09%
EPS Next 3Y7.48%
EPS Next 5Y3.62%
Revenue Next Year2.95%
Revenue Next 2Y3.92%
Revenue Next 3Y4.46%
Revenue Next 5Y3.12%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
DNOW Yearly Revenue VS EstimatesDNOW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
DNOW Yearly EPS VS EstimatesDNOW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.95, which indicates a rather expensive current valuation of DNOW.
DNOW's Price/Earnings ratio is in line with the industry average.
DNOW's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.63.
A Price/Forward Earnings ratio of 20.28 indicates a rather expensive valuation of DNOW.
The rest of the industry has a similar Price/Forward Earnings ratio as DNOW.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, DNOW is valued at the same level.
Industry RankSector Rank
PE 18.95
Fwd PE 20.28
DNOW Price Earnings VS Forward Price EarningsDNOW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DNOW indicates a somewhat cheap valuation: DNOW is cheaper than 60.42% of the companies listed in the same industry.
DNOW's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DNOW is cheaper than 95.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.76
EV/EBITDA 9.88
DNOW Per share dataDNOW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The decent profitability rating of DNOW may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.61
EPS Next 2Y2.09%
EPS Next 3Y7.48%

0

5. Dividend

5.1 Amount

No dividends for DNOW!.
Industry RankSector Rank
Dividend Yield N/A

DNOW INC

NYSE:DNOW (2/21/2025, 8:14:14 PM)

After market: 17.43 0 (0%)

17.43

-0.07 (-0.4%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-13 2025-02-13/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners101.96%
Inst Owner Change0.25%
Ins Owners1.98%
Ins Owner Change-1.37%
Market Cap1.84B
Analysts84.44
Price Target18.7 (7.29%)
Short Float %1.83%
Short Ratio1.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.08%
Min EPS beat(2)-1.96%
Max EPS beat(2)2.12%
EPS beat(4)2
Avg EPS beat(4)5.1%
Min EPS beat(4)-10.49%
Max EPS beat(4)30.72%
EPS beat(8)4
Avg EPS beat(8)5.08%
EPS beat(12)8
Avg EPS beat(12)32.91%
EPS beat(16)11
Avg EPS beat(16)46.35%
Revenue beat(2)0
Avg Revenue beat(2)-2.63%
Min Revenue beat(2)-3.38%
Max Revenue beat(2)-1.88%
Revenue beat(4)1
Avg Revenue beat(4)-1.92%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)0.61%
Revenue beat(8)3
Avg Revenue beat(8)-1.48%
Revenue beat(12)6
Avg Revenue beat(12)-0.23%
Revenue beat(16)10
Avg Revenue beat(16)0.56%
PT rev (1m)0%
PT rev (3m)4.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.86%
EPS NY rev (1m)-0.63%
EPS NY rev (3m)-7.85%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-4.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.4%
Valuation
Industry RankSector Rank
PE 18.95
Fwd PE 20.28
P/S 0.78
P/FCF 6.76
P/OCF 6.57
P/B 1.66
P/tB 2.13
EV/EBITDA 9.88
EPS(TTM)0.92
EY5.28%
EPS(NY)0.86
Fwd EY4.93%
FCF(TTM)2.58
FCFY14.8%
OCF(TTM)2.65
OCFY15.23%
SpS22.27
BVpS10.52
TBVpS8.19
PEG (NY)N/A
PEG (5Y)0.61
Profitability
Industry RankSector Rank
ROA 12.73%
ROE 18.13%
ROCE 11.11%
ROIC 8.78%
ROICexc 11.3%
ROICexgc 15.51%
OM 5.52%
PM (TTM) 8.57%
GM 22.78%
FCFM 11.58%
ROA(3y)8.68%
ROA(5y)-4.48%
ROE(3y)12.94%
ROE(5y)-6.15%
ROIC(3y)8.11%
ROIC(5y)N/A
ROICexc(3y)11.09%
ROICexc(5y)N/A
ROICexgc(3y)13.97%
ROICexgc(5y)N/A
ROCE(3y)10.26%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y18.32%
ROICexc growth 3YN/A
ROICexc growth 5Y23.94%
OM growth 3YN/A
OM growth 5Y20.91%
PM growth 3YN/A
PM growth 5Y44.48%
GM growth 3Y8.52%
GM growth 5Y2.73%
F-Score7
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 25.81%
Cap/Sales 0.34%
Interest Coverage 250
Cash Conversion 174.53%
Profit Quality 135.15%
Current Ratio 2.54
Quick Ratio 1.66
Altman-Z 3.91
F-Score7
WACC10.82%
ROIC/WACC0.81
Cap/Depr(3y)44.83%
Cap/Depr(5y)38.47%
Cap/Sales(3y)0.49%
Cap/Sales(5y)0.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.15%
EPS 3Y97.18%
EPS 5Y30.83%
EPS Q2Q%13.64%
EPS Next Y-6.59%
EPS Next 2Y2.09%
EPS Next 3Y7.48%
EPS Next 5Y3.62%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.88%
Revenue Next Year2.95%
Revenue Next 2Y3.92%
Revenue Next 3Y4.46%
Revenue Next 5Y3.12%
EBIT growth 1Y-9.09%
EBIT growth 3YN/A
EBIT growth 5Y13.91%
EBIT Next Year23.76%
EBIT Next 3Y9.1%
EBIT Next 5Y8.83%
FCF growth 1Y2375%
FCF growth 3Y-1.88%
FCF growth 5Y22.5%
OCF growth 1Y7125%
OCF growth 3Y-0.18%
OCF growth 5Y20.83%